FindTrial
Sign In

Comparison of dose response to two different doses of intravenous anaesthetic drug lidocaine for postoperative pain relief

Comparison of dose response to two different doses of intravenous lidocaine for postoperative analgesia in patients undergoing elective laparoscopic gynaecological oncology surgery under general anaesthesia : A Prospective randomised controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079593
Enrollment
30
Registered
2025-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C574- Malignant neoplasm of uterine adnexa, unspecified

Interventions

Intervention1: intravenous lidocaine infusion: Before induction of anaesthesia intravenous lidocaine bolus of 1.5mg/kg slowly over 10 mins followed by 2mg/kg/hr infusion after induction of anaesthesia

Sponsors

Dr Rakshitha K S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients aged between 18 and 65 years 2 Patients belonging to ASA physical status 1 and 2 3 Patients consenting for study

Exclusion criteria

Exclusion criteria: 1 Patients with cardiac, respiratory, hepatic or renal diseases. 2 Patients with neurological disorder. 3 Patients with history of alcohol or any drug addiction. 4 Pregnant or breastfeeding females. 5 Known allergic to local anaesthetics.

Design outcomes

Primary

MeasureTime frame
Assessing Visual Analogue Score(VAS) in postoperative periodTimepoint: 24 hours—

Secondary

MeasureTime frame
1. Intraoperative hemodynamic stability 2. Intraoperative requirement of opioids. 3. Assessing time to first analgesic dose and total consumption of rescue analgesic in 24 hours. 4. Side effects of intravenous lidocaine. Timepoint: 24 hours—

Countries

India

Contacts

Public ContactDr Sumitha C S

Kidwai memorial institute of oncology

cssumitha@yahoo.com9980524241

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026